Journal Information
Vol. 43. Issue S3.
Pages S19 (November 2021)
Share
Share
Download PDF
More article options
Vol. 43. Issue S3.
Pages S19 (November 2021)
OP 10
Open Access
ANTI-GLYCAN ANTIBODIES IN THE DIAGNOSIS OF GASTRIC CANCER
Visits
...
Nadezhda Shilova1, Maxim Nikulin2, Svetlana Polyakova1, Alexander Lipatnikov1, Maxim Navakouski1, Nicolai Tupitsyn2, Nicolai Bovin1
1 Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry Russian Academy of Science
2 National Medical Research Center of Oncology named after N. Blokhin
Article information
Objective

Gastric cancer (GC) is traditionally considered a difficult disease to diagnose and treat. The search for new markers for GC is an extremely urgent purpose. Previously has been shown, that serum anti-glycan antibodies (AGAT) are very large reservoir of markers which can be reliably detected using an instrument called glycoarray (PGA). A “;signature”; approach, i.e. searching of combinations of diagnostically significant markers – AGAT detected by PGA, is used in this study.

Methodology

The cohort of the serum of apparently healthy donors from the National Medical Research Center of Oncology (NMRC) (n = 55, 69%/31% - m/f) and previously untreated patients with an established diagnosis of GC I-IV stages from the NMRC (n = 146, 52%/48% - m/f) were collected. To study serum AGATs glycoarray containing 300 different glycans was used. To search for a diagnostic signature, the mathematical apparatus “;Immunoruler”; [Int. J. Bioinformatics Res. Appl., 7, 402-426 (2011)] was applied.

Results

Using glycoarray IgG and IgM profiles of donors and GC patients were obtained and data quality control has been performed. The mathematical apparatus Immunoruler was applied to the resulting database and a signature was obtained. It includes antibodies to 11 glycans: 7 IgM (directed to KDNb6’LN-C3, b3’SLN, LN-C8, Aa4A, TF, 3’SiaLeC and Tn3Su) and 4 IgG (GN6Su, TF, para-Fs and bGU). The quality of the developed diagnostic approach was assessed: the AUC value was 0.87, and the accuracy was 0.81.

Conclusion

Thus, the use of glycoarray technology in combination with a mathematical signature search apparatus has made it possible to find a reliable combination of molecular markers for the diagnosis of gastric cancer. Since the tumor can dramatically change as it progresses, the AGAT profile can also change. This opens up the possibility for a differentiated diagnosis of GC depending on the stage of the disease and, first of all, to develop early diagnosis of this disease.

Full text is only aviable in PDF
Idiomas
Hematology, Transfusion and Cell Therapy

Subscribe to our newsletter

Article options
Tools